BBK's Founding Principal and CEO Joan F. Bachenheimer discusses how BBK can help clinical trial sponsors respond to the immediate challenges resulting from the COVID-19 outbreak.
BBK's Founding Principal and CEO Joan F. Bachenheimer discusses how BBK can help clinical trial sponsors respond to the immediate challenges resulting from the COVID-19 outbreak.
Topics: Patient Engagement, Pharma15 Live!, Patient Enrollment, COVID-19, FDA Guidance, Coronavirus, Joan F. Bachenheimer